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Purpose. There is a relative paucity of self-reported vision problems data in European countries.  29 
Methods. In this context, we investigated self-reported vision problems through European Health 30 
Interview Survey 2, a cross-sectional European population survey based on a standardized 31 
questionnaire including 147 medical, demographic and socio-economic variables applied to non-32 
institutionalized individuals aged 15 years or more in 28 European countries, in addition to Iceland and 33 
Norway.  34 
Results. The survey included 311,386 individuals (54.18% women), with overall crude prevalence of 35 
self-reported vision problems of 2.07% [95%CI ; 2.01 - 2.14].  Among them, 1.70 % [1.61 – 1.78] of 36 
men, 2.41% [2.31 – 2.51] of women and 4.71% [4.53 - 4.89] of individuals aged 60 or more reported to 37 
have a lot of vision problems or to be not able to see. The frequency of self-reported vision problems 38 
was the highest in Eastern European countries with values of 2.43% [2.30 – 2.56]. In multivariate 39 
analyses, limiting long-standing illness, depression, daily smoking, lack of physical activity, lower 40 
educational level and social isolation were associated with self-reported vision problems with ORs of 41 
2.66 [2.42 - 2.92], 2.16 [2.01 – 2.32], 1.11 [1.01 - 1.23], 1.31 [1.21 - 1.42], 1.29 [1.19 - 1.40] and 1.45 42 
[1.26 - 1.67] respectively, while higher income was associated with less self-reported vision problems 43 
with OR of 0.80 [0.73 - 0.86].  44 
Conclusions. This study demonstrated inequalities in terms of prevalence of self-reported vision 45 
problems in Europe, with higher prevalence in Eastern European countries and among women and 46 
older individuals. 47 
 48 





In addition to reducing educational and economic opportunities, blindness and visual impairment have 53 
been linked to lower quality of life, shorter life expectancy and higher morbidity (Chakravarthy et al. 54 
2017; Wang et al. 2017; McCarty et al. 2001; Knudtson et al. 2006; Lee et al. 2002; Karpa et al. 2009; 55 
Cugati et al. 2007; Thiagarajan et al. 2005). Identification of factors that link vision problems with 56 
morbidity and premature death can assist with prevention and improve welfare of those with existing 57 
vision impairment.  58 
In 2017, the Global Burden of Disease Vision Loss Expert Group published a population-based 59 
prevalence study of visual impairment and blindness worldwide, followed by a paper focussing on 60 
prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe 61 
(Bourne et al. 2017; Bourne et al. 2018). In these comprehensive systematic reviews covering a 62 
twenty five-year period, the authors highlighted the paucity of data from Central and Eastern European 63 
countries. The European Health Interview Survey (EHIS 2), a European Union initiative, is a general 64 
population-based survey providing cross-sectional national data on health status, health determinants 65 
and healthcare activities in the European Union. In this study, we examined associations between self-66 
reported vision difficulties in the EHIS 2 and other variables included in the survey and other European 67 
socioeconomic variables.  68 
We sought to ascertain the association between self-reported vision problems and other variables of 69 
interest having a potential interaction with vision problems, identified through review of the literature. 70 
Specifically, we focused on medical history of diabetes and depression (Cosh et al. 2018; Yu et al. 71 
2019; Schubert et al. 2019; Aljied et al. 2018) and potential associated risk factors including smoking 72 
status (Mitchell et al. 2018; Nita et al. 2017a; Nita et al. 2017b), gender inequity (Bourne et al. 2017; 73 
Mganga H et al. 2011) and social isolation (Brunes et al. 2019). 74 
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Material and Methods 75 
Study design and population 76 
The study was performed under the auspices of the EUROVISION research program, funded by the 77 
European Union Horizon 2020 in 2018 (H2020-EU.1.3.2). The EUROVISION project aims to describe 78 
the prevalence of self-reported vision problems in European countries and to identify related 79 
demographic and socio-economic factors, health determinants and health care access issues. The 80 
European Health Interview Survey (EHIS 2) was performed between 2013 and 2015 and was 81 
designed to include population-based samples representative of the European population aged 15 82 
years and older. People living in collective households or institutions were excluded from this survey. 83 
The survey was conducted in 28 member states of the European Union and in two neighbouring 84 
countries (Iceland and Norway).  85 
Procedures 86 
The sampling frame was defined from population census, population registers, dwelling registers, 87 
national health insurance registries, postcode address files or samples from the Labour Force Survey, 88 
depending on the countries participating in the survey. Using standardized questionnaires, the data 89 
were collected by face-to-face or telephone interviews, regular mail, email or through the internet, with 90 
the majority of the data originating from telephone and face-to-face interviews. Eurostat recommended 91 
a minimal required sample size of 7,000 individuals per country. This sample size was not reached for 92 
member states with a small population (Slovakia, Slovenia, Sweden, Malta, Luxembourg, Lithuania, 93 
Iceland, Hungary, Croatia, Finland, Estonia, Denmark, Czech Republic, Cyprus and Belgium). For all 94 
these countries, except Malta, Luxembourg and Iceland, the number of respondents was above 5,000 95 
(Fig. 1).  96 
The standardized questionnaire included four different modules comprising a demographic and socio-97 
economic component and public health category divided into a European health status module, a 98 
European health determinant module and a European health care module (Table 1). The 99 




Categorising variables  103 
From the original age groups, two alternative categorizations have been created. First, in order to 104 
account for varying top-coding across countries, age groups 75-79, 80-84, 80+ and 85+ have been 105 
merged in one group (75+). These groups were used for the global and region-wise univariate 106 
analysis, the multivariate analysis and for age-standardization. Second, in order to reach a large 107 
enough sample size in each group to obtain reliable results for logistic regression within each country, 108 
adult individuals have been pooled in the following groups 18-29, 30-39, 40-49, 50-59, 60-69 and 70+. 109 
These groups were used for the individual countries univariate analysis. 110 
Two groups pertaining to vision status were defined: “no vision problems” and “vision problems”. 111 
These groups were derived from the variable named PL2 (“Difficulty in seeing, even when wearing 112 
glasses or contact lenses”). The possible answers were 1: “No difficulty”, 2: “Some difficulty”, 3: “A lot 113 
of difficulty”, 4: “Cannot do at all / unable to do”. Individuals who answered 3 or 4 were included in the 114 
“vision problems” group. Those who did not answer were excluded. We defined ‘unmet need’ for 115 
optical correction as the proportion of respondents within the “vision problems” group who also 116 
reported not wearing an optical correction. 117 
Associated factors 118 
Aside from age and gender, other variables were created to investigate their association with vision 119 
difficulties. These variables included education, wealth, health, daily smoking, daily alcohol 120 
consumption, physical activity, depression, chronic conditions, functional limitations (for respondents 121 
aged 65 years or more), limiting longstanding illness and social isolation. 122 
Education was categorized into three levels: “low” for pre-primary to lower secondary education, 123 
“intermediate” for upper secondary to short cycle tertiary education, and “higher” for tertiary education 124 
and above. Wealth was coded in two levels: “low” for income in the lowest quintile and “higher” for 125 
income in the other quintiles. Self-assessed health was coded in two levels: “good” for respondent who 126 
judged their health “good” or “very good”, “poor” for those who answered “fair”, “bad” or very “bad”. 127 
Physical activity was coded “yes” if the respondent walked, used a bike, practiced sports, fitness or 128 
recreational physical activities for 30 minutes or more at least once a week, and “no” otherwise. 129 
Depression was assessed by either a response confirming depression, or from scoring more than 130 
three negative responses out of six items relating to mental well-being (chosen to be as similar as 131 
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possible to the Center for Epidemiologic Studies-Depression scale). Chronic condition indicators 132 
included self-reported diabetes, heart problems (coronary heart disease, angina pectoris or myocardial 133 
infarction) and stroke. The chronic condition indicators were combined into a single indicator variable 134 
encoding “one or more chronic conditions”. Functional limitations were assessed by different items 135 
including difficulty walking half a kilometre on level ground, difficulty walking up or down 12 steps, 136 
difficulty feeding oneself, difficulty getting in and out of a bed or chair, difficulty dressing and 137 
undressing, difficulty using toilets, and difficulty in bathing or showering. These items were combined in 138 
a single indicator variable encoding “one or more functional limitations”. This variable was only defined 139 
for respondents aged 65 years and older. Social isolation was assessed by combining the following 140 
variables: partnership status and inadequate financial support. Respondents who were single and had 141 
inadequate financial support were deemed socially isolated. Respondents were defined as either living 142 
as a couple (married or not) or single according to their reported marital and consensual union status. 143 
Inadequate financial support was assessed by the inability of respondents to afford medical 144 
examination or treatment over the past 12 months. A more detailed definition of these variables is 145 
provided in Supporting Information (Table S1.) 146 
Additional data 147 
In addition to the data collected through the questionnaires, other country-level socioeconomic 148 
indicators relating to each country corresponding to the time of the EHIS survey were included in the 149 
analyses. The Human Development Index (HDI), the Gender Inequality Index (GII) and the Inequality 150 
adjusted human development index (IHDI) were obtained from the United Nations Development 151 
Programme (http://hdr.undp.org/en/indicators/137506).  The Gross Domestic Product per capita 152 
(GDP), Current Health Expenditure (CHE) and out-of-pocket expenditure (% of current health 153 
expenditure) were obtained from the World Bank (https://data.worldbank.org/indicator). 154 
Countries participating in the survey were grouped in four European regions defined by the United 155 
Nations as follows. Western Europe: Germany, Austria, Belgium, France, Luxembourg and The 156 
Netherlands; Eastern Europe: Bulgaria, Hungary, Poland, Czech Republic, Romania and Slovakia; 157 
Northern Europe: Norway, Iceland, Ireland, Lithuania, Latvia, UK, Sweden, Finland, Denmark and 158 
Estonia; Southern Europe: Croatia, Spain, Greece, Italy, Malta, Portugal and Slovenia. Note that while 159 
not part of any region, Cyprus was included in the overall analysis. 160 
8 
Statistical analysis 161 
All analyses were performed using the survey unit weights supplied within the EHIS 2 dataset. These 162 
made adjustments to the crude data to enhance the representativeness of the survey data in relation 163 
to the sampled national population. According to the survey guidelines, they were specified to allow for 164 
overall calculations and inter-country comparisons, and accounted for sampling design, non-response, 165 
gender and age structure of the populations, and (in some of the datasets) also regional distribution 166 
and educational attainment. The SAS procedure surveyfreq was used to compute crude prevalence 167 
and associated 95% confidence intervals (CI) taking these weights into account. 168 
Odds-ratios and their 95% CI were computed using logistic regression (SAS surveylogistic procedure), 169 
adjusting for age and sex. For the univariate analysis, only complete observations for the variable of 170 
interest (without missing data) were used. For the multivariate analyses, data imputation was first 171 
carried out due to the small proportion of complete observations across all variables of interest (61%), 172 
and also to mitigate possible bias due to a few countries not asking some questions.  173 
Age-adjusted prevalence and 95% CIs were computed using the direct method (SAS stdrate 174 
procedure). The reference population was taken to be the 5-year wide European (28) population data 175 
from Eurostat (https://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=demo_pjan&lang=en). The 176 
average was taken for the period from 2013-2015.  177 
Least-square linear regression (SAS reg procedure) was used for the regression analyses.  178 
All analyses were performed with SAS/STAT software, version 9.4 of the SAS System for Windows. 179 
Copyright © 2016 by SAS Institute Inc. All figures were created using GraphPad Prism version 5.03 for 180 




EHIS 2 included 316,333 participants of whom 4,947 (1.6%) were excluded because of missing vision 184 
status data. The analysed sample thus consisted of 311,386 respondents (54.18% women), including 185 
302,093 adults aged 18 or older and 9,293 teenagers aged 15 to 17 years old (2.98%). Age group 186 
sizes ranged from 6,938 (ages 18-19) to 27,589 (ages 50-54). Of the sample analysed, 55.81% of 187 
men and 66.37% of women reported that they wore glasses or contact lenses, and 1.84% of men and 188 
2.91% of women reported vision problems. 189 
The overall crude prevalence of self-reported vision problems was 2.07% [2.01 - 2.14].  Among people 190 
reporting vision problems in Europe (2.07%), almost a quarter (26%) did not report using optical 191 
correction (0.54%). The unmet need for optical correction despite vision problems was  20% in 192 
Eastern, 25% in Northern, 30% in Southern and 41% in Western European regions. Considering the 193 
analysis by region and country, respondents in Southern and Western European countries showed 194 
similar crude prevalence of self-reported vision problems with values of 2.29% [2.17 – 2.41] and 195 
2.17% [2.03 – 2.31] respectively (OR and 95% CI for Western vs Southern country: 1.01 [0.92 - 1.09]). 196 
On the other hand, Eastern and Northern countries respectively had the highest and lowest crude 197 
prevalence with values of 2.43% [2.30 – 2.56] and 1.25% [1.14 – 1.36] (OR and 95% CI for Northern 198 
vs Eastern country: 0.49 [0.44 - 0.54]). The remaining ORs and 95% CI are as follows: Southern vs 199 
Eastern: 0.82 [0.76 - 0.89]; Western vs Eastern: 0.83 [0.76 – 0.90]; Southern vs Northern: 1.69 [1.52 – 200 
1.88]; Western vs Northern: 1.70 [1.52 – 1.91]. Among each region, there were considerable inter-201 
country differences, ranging from 0.86 [0.66 - 1.06] and 0.86 [0.59 – 1.13] in Ireland and Malta 202 
respectively to 4.31% [3.91 – 4.70] and 6.48 [5.76 – 7.19] in Portugal and Belgium respectively. These 203 
data are detailed by region and by country for three age groups (< 18, 18-65, ≥ 60 years old) and by 204 
gender in table 2.  205 
Women reported significantly more vision problems than men did with overall age-adjusted prevalence 206 
of self-reported vision problems of 2.41% [2.31 – 2.51] vs 1.70 % [1.61 – 1.78] respectively (OR and 207 
95% CI: 1.43 [1.34 – 1.54]). 208 
Among older participants, women reported more vision problems than males, with an age-adjusted 209 
prevalence of 5.65% [5.38 – 5.92] for women and 3.62% [3.40 - 3.84] for males in the age group of 210 
60+ years (OR and 95% CI: 1.60 [1.47 – 1.74]), reaching 17.22% [15.68 – 18.76] for women and 211 
10 
11.85% [10.25 – 13.45] for males in the age group of 85+ years (OR and 95% CI: 1.55 [1.28 – 1.87]). 212 
These results are displayed in Table 3.  213 
The association between various factors of interest and self-reported vision problems was investigated 214 
in adults (18 years old and older). Among other factors, depression and social isolation were 215 
associated with vision problems, with ORs of 4.55 [4.20 - 4.93] and 2.79 [2.43 - 3.21], respectively. 216 
Among those aged 65 years and more, functional limitations were associated with ORs of self-217 
reported vision problems of 6.04 [5.31 - 6.87]. These results of the univariate analysis are detailed in 218 
table 4. Poor self-rated health, limiting long-standing and chronic illness, daily smoking were 219 
associated with more self-reported vision problems with ORs of 4.48 [4.11 - 4.89], 5.23 [4.82 - 5.67], 220 
2.53 [2.34 - 2.73], 1.35 [1.23 - 1.48] respectively, while higher wealth and education level were 221 
associated with less self-reported vision problems, with ORs of 0.60 [0.55 - 0.65] and 0.77 [0.68 - 0.87] 222 
respectively. The results of the univariate analysis by region and countries are detailed in Fig. 2 and in 223 
supporting Information (Table S2). 224 
Multivariate regression analysis between self-reported vision problems and health, socio-economic 225 
and life style related variables showed that limiting long-standing illness and depression were 226 
associated with self-reported vision problems with ORs of 2.66 [2.42 - 2.92] and 2.16 [2.01 - 2.32] 227 
respectively. Smoking, physical activity, education level, economic status, and social isolation were 228 
also associated with self-reported vision problems. These results are detailed in table 5. 229 
No statistically significant association between age-adjusted prevalence and socioeconomic indicators 230 
was found at the country level.231 
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Discussion 232 
The EHIS2 population-based survey provides data on self-reported vision problems and associated 233 
factors for 30 countries in Europe, country by country. The crude overall prevalence of self-reported 234 
vision problems was 2.07% [2.01 – 2.14].  235 
For those aged 60 years or more, the crude prevalence of vision problems was 4.71% [4.53 – 4.89]. 236 
These results are slightly different from other population-based studies of self-reported vision status in 237 
other high-income regions including the National Health Interview Survey (NHIS) (Lam et al. 2009), the 238 
National Health and Nutrition Examination Survey IV (NHANES IV) (Coyle et al. 2017) and the English 239 
Longitudinal Study on Ageing (ELSA) (Jackson et al. 2019). The comparison of self-reported vision 240 
problems prevalence in these different population-based studies is detailed in supporting Information 241 
(Table S3). 242 
It is likely that these differing results firstly reflect the variability in the wording of visual health 243 
questions included in different surveys. Secondly they reflect differing categorisation of responses, 244 
making meaningful comparison between studies challenging. For example, in the NHIS, visual health 245 
questions were “Do you have any trouble seeing, even when wearing glasses or contact lenses?” and 246 
“Are you blind or unable to see at all?”. Participants were classified as visually impaired if they 247 
responded yes to either question (Lam et al. 2009). In the NHANES IV, participants were asked to rate 248 
their corrected vision as excellent, good, fair, poor or very poor. Three groups were defined from the 249 
answers: poor or very poor vision, vision categorised as fair, and good or excellent vision for the 250 
reference group (Coyle et al. 2017). This categorisation of self-reported vision problems was different 251 
to that which we used for EHIS 2, in which we reduced this categorisation from four levels to two 252 
categories of vision problems. In ELSA, participants were asked if their corrected eyesight was 253 
excellent, very good, good, fair or poor. Respondents reporting fair or poor vision were classified in the 254 
“poor vision” group (Yu et al. 2019) whereas the criteria used to define “vision problems” group in the 255 
current study were more conservative. These differences are likely to explain the variability of 256 
observed prevalence of self-reported vision problems for similar age groups. In this context, we 257 
strongly support Rein, D.B. and colleagues in advocating improved standardisation of the phrasing of 258 
self-reported vision status questions, to enhance both reproducibility and comparability of national 259 
population-based surveys (Rein et al. 2018). 260 
12 
The Sustainable Development Goals (SDGs), adopted by the United Nations General Assembly in 261 
2015, provide a new global policy framework aiming at fighting inequalities in social, economic, health 262 
and environmental aspects. Among the first five SDGs, are “no poverty” (1st), “good health and well-263 
being” (3rd), “quality of education” (4th) and “gender equality” (5th). Through the present analysis of the 264 
EHIS data, we were able to gain some insight into the association between the SDGs and vision 265 
impairment by the inclusion of gender, socioeconomic (income, education, social isolation and 266 
discrimination) and health data (smoking, chronic illness and functional limitation, depression). 267 
Exploring this further, it becomes apparent that women and older respondents were more prone to 268 
report vision problems. Indeed, the age-adjusted prevalence of self-reported vision problems was 269 
2.41% [2.31 – 2.51] for women in EHIS 2, compared to 1.70% [1.61 – 1.78] for males (OR and 95% 270 
CI: 1.43 [1.34 – 1.54]). Furthermore, when focusing on the elderly population, the age-adjusted 271 
prevalence of vision problems was consistently higher among women than males (Table 3). In the 272 
European population, this gender difference could reflect better self-awareness of vision impairment or 273 
less tolerance to poor vision in women, or true gender differences in the prevalence of vision 274 
impairment, relating to differences in the prevalence of underlying eye disease or to differential access 275 
to eye-care services and treatments. Comparison to other studies is difficult because data on the 276 
association between gender and self-reported vision problems are lacking. However, our results are 277 
very similar to a population-based Canadian study, which reported that the prevalence of self-reported 278 
uncorrected vision problems was 2.0% among women and 1.3% among males (Perruccio et al. 2010). 279 
More widely, inequality between women and males has been reported in a systematic review (Bourne 280 
et al. 2017). In that review, the authors observed that the prevalence of blindness and moderately or 281 
severely impaired vision was higher in women than in males for all age groups (0-49, 50-69 and ≥70). 282 
In line with other population-based studies, the current study confirmed that older individuals carry a 283 
much higher risk of visual impairment. In EHIS 2, the crude prevalence of vision problems among 284 
respondents aged 70+ years was 6.88%, while the prevalence of poor vision and legal blindness was 285 
reported to be 9.08% in the 2010 Health and Retirement Study (HRS) including Americans aged 70+ 286 
years (Chen et al. 2016). In the US, the Vision and Eye Health Surveillance System (VEHSS) in the 287 
American community survey based on IRIS registry estimated that 5.60% [95% CI: 5.50 - 5.70] of 288 
individuals aged 65-84 years and 17% [95% CI: 16.80 - 17.60] of individuals aged 85+ years 289 
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considered themselves to be blind or to have serious difficulties in seeing, even when wearing 290 
glasses.  291 
Our univariate logistic regression analysis showed that even for respondents in the same country, both 292 
higher income and higher education levels were protective factors for self-reported vision problems, 293 
with ORs of 0.60 [0.55 - 0.65] and of 0.77 [0.68 - 0.87], respectively. These results were partially 294 
confirmed in multivariate analyses which showed that higher income had a protective effect, with OR 295 
of 0.80 [0.73 – 0.86] while lower education level increased the risk with an OR of 1.29 [1.19 – 1.40].  296 
Lower income has been frequently reported among blind or visually impaired individuals (Brézin et al. 297 
2005). A recent study investigating the prevalence of visual impairment under the scope of 298 
socioeconomic factors at country level, showed that a higher Human Development Index and 299 
Education Index were associated with a lower prevalence of blindness or moderate and severe visual 300 
impairment (Wang et al. 2017). Meanwhile, lower total health expenditure per capita and total health 301 
expenditure by Gross Domestic Product were associated with higher prevalence (Wang et al. 2017). 302 
We also analysed the relationship between socioeconomic indicators and self-reported vision 303 
problems at the country level, but no significant association with a country’s HDI, IHDI, GDP, out of 304 
pocket expenditure, MPI and GII could be established. This may be because socioeconomic level 305 
does not differ sufficiently among member states to detect significant difference, but it is more likely 306 
that the socioeconomic associations we found at survey participant level are not reflected by the rather 307 
crude comparison of country-level summary measures like these. Moreover, the small number of data 308 
points (30 countries) fundamentally limits the power of this analysis. 309 
In agreement with other studies (Bourne et al. 2018), the current study also showed that self-reported 310 
vision problems were still more prevalent in Eastern  (2.43%) than in Northern (1.25%), Western 311 
(2.17%) and Southern (2.29%) European countries while the unmet needs of optical correction was 312 
the lowest in Eastern European countries (20%, see Table 2). In this context, it is likely that impact of 313 
ocular diseases on vision is more important than in other European regions. For Eastern countries, it is 314 
likely that a favourable economic evolution has not yet completely led to medical policies guaranteeing 315 
an improved access to affordable medical care. Furthermore, positive economic growth does not 316 
necessarily equate to reduced inequalities between individuals, as can be clearly observed from data 317 
on the Gini coefficient of equivalised disposable income published by EU-SILC 318 
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(https://ec.europa.eu/eurostat/web/microdata/european-union-statistics-on-income-and-living-319 
conditions). We also investigated if the payment by the national social system for eye examinations in 320 
the elderly (50+) has an impact on self-declared vision problems. There was apparently no correlation, 321 
probably because many other factors can also interact such as the pocket-to-pocket expenditure for 322 
eye examination or the level of reimbursement of optical correction by social security or by insurances. 323 
In parallel to socioeconomic aspects, social isolation, a variable defined by combining celibacy and 324 
inadequate financial support, was a related risk factor for vision problems in the univariate analyses. 325 
Our cross-sectional study also supports previous published studies which reported an association 326 
between visual impairment and depression, particularly in the elderly population (Yu et al. 2019; 327 
Rovner et al. 1997; Evans et al. 2007; Goldstein et al. 2012; Ribeiro et al. 2015; Van der Aa et al. 328 
2015; Yip et al. 2014).  329 
Multivariate analysis also showed that smoking status was a related risk factor for self-reported vision 330 
problems, with an OR of 1.11 [1.01 – 1.25] for smokers compared with non-smokers (Table 5). Other 331 
studies found similar results (Zhang et al. 2011).The association between smoking and vision 332 
problems could be explained by an increased risk of cataract (Kang et al. 2016) and age-related 333 
macular degeneration (AMD) among smokers (Christen et al. 1996; Age-Related Eye Disease Study 334 
Research Group et al. 2000; Klein et al. 2004). 335 
We acknowledge some weaknesses in the current study. Firstly, some questions of interest were not 336 
asked in a few countries, which rendered difficult the comparison of odds ratios between different 337 
variables, and between the univariate and the multivariate analyses for the same variable. Secondly, 338 
heterogeneity between countries in the data gathering process may have been a source of 339 
measurement or selection bias, and this should be kept in mind when interpreting the results. While 340 
the prevalence of self-reported vision problems by age group, country and gender provides a useful 341 
pan-European insight into the epidemiology of self-reported vision impairment, the cross-sectional 342 
nature of the study design did not enable us to establish causal links between vision problems and 343 
explanatory variables. Thirdly, the study design of the survey did exclude people living in collective 344 
households or institutions, probably leading to an under-estimation of self-reported vision problems in 345 
the whole European population. Finally, the NEI-VFQ-25 questionnaire was not used into this survey 346 
because it was dedicated not only to vision problems, but also to wider aspects of health determinants, 347 
which are not explored with the NEI-VFQ-25 questionnaire. The EHIS 2 survey questionnaire was 348 
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tested on population samples in different countries before being used widely on the European scale. 349 
Considering the few questions related to vision in EHIS 2, they were validated by the Washington 350 
Group on Disability Statistics short set of question that provided evidence that these questions were 351 
able to capture different aspects of difficulties  in seeing. 352 
We did not use Rasch analysis to map item responses to individual abilities, because this approach 353 
has several drawbacks. First, the resulting model would be much more difficult to interpret. 354 
Specifically, dependent variables values expressed in logits might no longer be related, even partially, 355 
to answers to questionnaire items. Moreover, the resulting effect size expressed in odds ratio in the 356 
current study could no longer be interpretable in simple terms, which would limit our results to 357 
“positively or negatively associated”. Second, as this approach is not currently widespread in the 358 
epidemiology community, its use would have rendered our results less accessible.There are only a 359 
few published European population-based studies on prevalence of vision impairment and blindness 360 
(measuring visual acuity of participants rather than self-reporting) by cause, some of them focusing on 361 
specific European countries (Munier et al. 1998; Cruciani et al. 2011; Finger et al. 2012; Havstam 362 
Johansson et al. 2020) and others having a more global focus (Bourne et al. 2018; Flaxman et al. 363 
2017; Németh et al. 2019). According to the Vision Loss Expert Group, uncorrected refractive errors, 364 
cataract, AMD and glaucoma, i.e. entirely or partly curable pathologies, were still the main causes of 365 
both blindness and moderately to severely impaired vision in Western, Central and Eastern European 366 
countries (Bourne et al. 2018). Nevertheless, population-based data on the prevalence and causes of 367 
vision problems, stratified by region and by age group, are still missing for most European Union 368 
member states. In that respect, the EHIS 2, developed and funded by the European Union represents 369 
an excellent opportunity to gather data on the health status, health care use and health determinants 370 
in every member state. These data, in turn, should be useful for European and local public health 371 
policies in their efforts to improve access to health services for all and to decrease inequalities 372 
(Németh et al. 2019). A strength of our study is the large size of the representative population sample, 373 
which allowed the analyses to be carried out at the level of participating countries, namely member 374 





This cross-sectional European population-based study demonstrates inequalities between European 379 
Union member states in terms of crude prevalence of self-reported vision problems, ranging from 380 
0.86% (in Ireland and Malta) to 6.48% (in Belgium) in the general population, with higher prevalence in 381 
Eastern European countries. Furthermore, self-reported vision problems in Europe were more 382 
frequently observed in the elderly, women, smokers, and in those reporting greater social isolation. 383 
Higher prevalence of eye disorders in older individuals combined with other physical limitations, better 384 
self-awareness of vision problems and economic restrictions limiting access to eye-care services could 385 
explain these differences. Given that this study reports 26% of people with an unmet need for optical 386 
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Figure. 1 Sample size and total weight for EHIS 2. a) Sample size (number of respondents). b) 515 
Targeted population (sum of unit weights) 516 
Figure. 2 Odds ratios and 95% confidence intervals from the univariate regression analysis between 517 
vision problems and variables of interest, by region and by country, in adult population. Only variables 518 
defined from questions answered by all countries were included, namely: a) Self-assessed health 519 
(poor vs good); b) limiting longstanding illness (yes vs no); c) chronic illness (yes vs no); d) daily 520 
smoking (yes vs no); e) wealth (high vs low); f) education (low vs intermediate); g) education (high vs 521 
intermediate). 522 
The ORs of the education variable could not be computed for Malta and Portugal because no survey 523 





European Health Status 
Module 
 
European Health Determinants 
Module 
European Health Care 
Module 
Health status  Weight and height  Use of inpatient and day care 
services  
Specific diseases & chronic 
conditions   
Physical activity  
 
Use of ambulatory and home 
care  
 
Occurrence of accidents and 
injuries 
Consumption of fruits and vegetables  
 
Medicine use  
 
Absence from work (health 
problems)  
Smoking behaviour  
 
Use of preventive services  
Physical & sensory functional 
limitations  
Alcohol consumption  
 
Unmet needs for health care  
Difficulties with personal care 
activities  
Social support  
 
 
Difficulties with household 
activities 
Provision of informal care or assistance 
 
 
Having pain  
Specific aspects of mental 
health  
 528 
Table 1. Composition of public health modules developed into the questionnaires 529 
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    Age Need for optical correction 
  All 15-17 18-59 60+ Met Unmet 
Europe 2.07 [2.01 - 2.14] 
N = 311,386 
0.49 [0.30 - 0.68] 
N = 9,293 
1.02 [0.96 - 1.08] 
N = 194,912 
4.71 [4.53 - 4.89] 
N = 107,181 
1.53 [1.47 - 1.59] 
N = 191,603 
0.54 [0.51 - 0.58] 
N = 119,783 
East 2.43 [2.30 - 2.56] 
N = 65,182 
0.52 [0.21 - 0.83] 
N = 2,024 
0.94 [0.83 - 1.04] 
N = 40,257 
6.34 [5.96 - 6.71] 
N = 22,901 
1.94 [1.83 - 2.06] 
N = 32,534 
0.49 [0.43 - 0.55] 
N = 32,648 
Bulgaria 
2.10 [1.76 - 2.44] 
N = 6,400 
0.00 [0.00 - 0.00] 
N = 188 
0.43 [0.23 - 0.64] 
N = 3,829 
5.64 [4.68 - 6.60] 
N = 2,383 
1.40 [1.12 - 1.68] 
N = 2,978 
0.70 [0.50 - 0.90] 
N = 3,422 
Czech 
Republic 2.04 [1.71 - 2.38] 
N = 6,737 
0.00 [0.00 - 0.00] 
N = 120 
0.88 [0.53 - 1.22] 
N = 3,408 
4.79 [4.00 - 5.58] 
N = 3,209 
1.78 [1.46 - 2.09] 
N = 4,507 
0.27 [0.15 - 0.38] 
N = 2,230 
Hungary 
2.63 [2.21 - 3.06] 
N = 5,825 
1.76 [0.00 - 3.77] 
N = 204 
1.54 [1.15 - 1.93] 
N = 3,891 
5.20 [4.11 - 6.29] 
N = 1,730 
1.79 [1.44 - 2.15] 
N = 2,899 
0.84 [0.60 - 1.08] 
N = 2,926 
Poland 
3.17 [2.92 - 3.41] 
N = 24,125 
0.80 [0.25 - 1.35] 
N = 874 
1.25 [1.05 - 1.44] 
N = 15,390 
8.53 [7.80 - 9.27] 
N = 7,861 
2.66 [2.44 - 2.88] 
N = 13,343 
0.51 [0.41 - 0.61] 
N = 10,782 
Romania 
1.62 [1.42 - 1.82] 
N = 16,605 
0.00 [0.00 - 0.00] 
N = 498 
0.39 [0.26 - 0.51] 
N = 10,104 
4.86 [4.23 - 5.49] 
N = 6,003 
1.18 [1.02 - 1.35] 
N = 5,702 
0.43 [0.33 - 0.54] 
N = 10,903 
Slovakia 
1.10 [0.84 - 1.35] 
N = 5,490 
0.00 [0.00 - 0.00] 
N = 140 
0.43 [0.23 - 0.64] 
N = 3,635 
3.20 [2.37 - 4.04] 
N = 1,715 
1.00 [0.76 - 1.25] 
N = 3,105 
0.09 [0.02 - 0.16] 
N = 2,385 
North 1.25 [1.14 - 1.36] 
N = 76,999 
0.48 [0.12 - 0.83] 
N = 2,203 
0.77 [0.65 - 0.90] 
N = 45,941 
2.50 [2.25 - 2.75] 
N = 28,855 
0.93 [0.84 - 1.03] 
N = 50,878 
0.32 [0.26 - 0.38] 
N = 26,121 
Denmark 
1.00 [0.75 - 1.25] 
N = 5,510 
0.50 [0.00 - 1.48] 
N = 163 
0.67 [0.40 - 0.95] 
N = 3,169 
1.81 [1.23 - 2.40] 
N = 2,178 
0.59 [0.40 - 0.78] 
N = 3,910 
0.41 [0.25 - 0.57] 
N = 1,600 
Estonia 
2.25 [1.86 - 2.65] 
N = 5,449 
0.81 [0.00 - 2.40] 
N = 185 
0.65 [0.39 - 0.92] 
N = 3,440 
6.15 [4.98 - 7.33] 
N = 1,824 
1.68 [1.34 - 2.02] 
N = 3,364 
0.57 [0.36 - 0.78] 
N = 2,085 
Finland 
1.92 [1.57 - 2.27] 
N = 5,982 
0.00 [0.00 - 0.00] 
N = 178 
1.31 [0.91 - 1.71] 
N = 3,287 
3.38 [2.63 - 4.13] 
N = 2,517 
1.59 [1.27 - 1.91] 
N = 4,446 
0.34 [0.19 - 0.49] 
N = 1,536 
Iceland 
1.13 [0.80 - 1.46] 
N = 3,991 
0.00 [0.00 - 0.00] 
N = 227 
0.81 [0.45 - 1.16] 
N = 2,680 
2.37 [1.47 - 3.27] 
N = 1,084 
0.93 [0.64 - 1.23] 
N = 2,459 
0.20 [0.06 - 0.34] 
N = 1,532 
25 
Ireland 
0.86 [0.66 - 1.06] 
N = 9,567 
0.00 [0.00 - 0.00] 
N = 74 
0.59 [0.37 - 0.82] 
N = 5,986 
1.90 [1.42 - 2.38] 
N = 3,507 
0.63 [0.45 - 0.80] 
N = 6,229 
0.23 [0.13 - 0.33] 
N = 3,338 
Latvia 
2.69 [2.32 - 3.06] 
N = 7,068 
0.00 [0.00 - 0.00] 
N = 241 
0.87 [0.57 - 1.16] 
N = 4,296 
7.06 [6.04 - 8.08] 
N = 2,531 
1.47 [1.20 - 1.74] 
N = 2,892 
1.22 [0.96 - 1.48] 
N = 4,176 
Lithuania 
2.05 [1.69 - 2.41] 
N = 5,205 
1.02 [0.00 - 2.43] 
N = 194 
0.81 [0.50 - 1.12] 
N = 3,139 
5.11 [4.12 - 6.10] 
N = 1,872 
1.42 [1.12 - 1.72] 
N = 2,622 
0.63 [0.43 - 0.83] 
N = 2,583 
Norway 
0.92 [0.68 - 1.16] 
N = 8,161 
0.65 [0.00 - 1.61] 
N = 319 
0.62 [0.39 - 0.85] 
N = 5,467 
1.72 [1.05 - 2.39] 
N = 2,375 
0.71 [0.50 - 0.92] 
N = 5,184 
0.21 [0.10 - 0.33] 
N = 2,977 
Sweden 
1.60 [1.25 - 1.95] 
N = 5,939 
0.22 [0.00 - 0.64] 
N = 274 
1.10 [0.77 - 1.42] 
N = 4,051 
2.87 [1.96 - 3.78] 
N = 1,614 
1.13 [0.83 - 1.42] 
N = 3,868 
0.47 [0.28 - 0.67] 
N = 2,071 
United 
Kingdom 1.11 [0.95 - 1.27] 
N = 20,127 
0.58 [0.00 - 1.17] 
N = 348 
0.72 [0.54 - 0.91] 
N = 10,426 
2.15 [1.80 - 2.49] 
N = 9,353 
0.86 [0.72 - 0.99] 
N = 15,904 
0.25 [0.16 - 0.34] 
N = 4,223 
South 2.29 [2.17 - 2.41] 
N = 89,132 
0.46 [0.12 - 0.80] 
N = 2,406 
0.92 [0.82 - 1.02] 
N = 54,071 
5.47 [5.15 - 5.78] 
N = 32,655 
1.60 [1.51 - 1.70] 
N = 53,854 
0.69 [0.62 - 0.75] 
N = 35,278 
Croatia 
2.95 [2.47 - 3.43] 
N = 5,396 
1.48 [0.00 - 3.29] 
N = 185 
1.12 [0.73 - 1.51] 
N = 3,272 
7.10 [5.80 - 8.40] 
N = 1,939 
2.36 [1.92 - 2.80] 
N = 2,871 
0.59 [0.38 - 0.80] 
N = 2,525 
Greece 
2.28 [1.96 - 2.61] 
N = 8,216 
0.00 [0.00 - 0.00] 
N = 120 
0.63 [0.39 - 0.87] 
N = 4,734 
5.98 [5.08 - 6.87] 
N = 3,362 
1.81 [1.53 - 2.09] 
N = 4,719 
0.47 [0.31 - 0.63] 
N = 3,497 
Italy 
2.04 [1.85 - 2.22] 
N = 24,256 
0.50 [0.00 - 1.00] 
N = 793 
0.73 [0.58 - 0.87] 
N = 15,046 
4.77 [4.29 - 5.25] 
N = 8,417 
1.51 [1.35 - 1.66] 
N = 13,861 
0.53 [0.43 - 0.62] 
N = 10,395 
Malta 
0.86 [0.59 - 1.13] 
N = 4,045 
1.13 [0.00 - 3.33] 
N = 109 
0.37 [0.14 - 0.60] 
N = 2,459 
2.04 [1.32 - 2.77] 
N = 1,477 
0.65 [0.42 - 0.89] 
N = 2,715 
0.21 [0.07 - 0.35] 
N = 1,330 
Portugal 
4.31 [3.91 - 4.70] 
N = 18,194 
0.22 [0.00 - 0.58] 
N = 435 
2.41 [2.02 - 2.80] 
N = 10,503 
8.79 [7.85 - 9.73] 
N = 7,256 
2.79 [2.48 - 3.10] 
N = 11,086 
1.52 [1.27 - 1.76] 
N = 7,108 
Slovenia 
2.50 [2.08 - 2.93] 
N = 6,195 
0.41 [0.00 - 1.22] 
N = 243 
1.28 [0.89 - 1.66] 
N = 3,978 
5.64 [4.49 - 6.78] 
N = 1,974 
2.03 [1.65 - 2.41] 
N = 3,723 
0.47 [0.28 - 0.67] 
N = 2,472 
Spain 
2.10 [1.89 - 2.31] 
N = 22,830 
0.47 [0.00 - 1.18] 
N = 521 
0.87 [0.69 - 1.05] 
N = 14,079 
5.39 [4.81 - 5.98] 
N = 8,230 
1.33 [1.17 - 1.49] 
N = 14,879 
0.77 [0.64 - 0.90] 
N = 7,951 
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West 2.17 [2.03 - 2.31] 
N = 75,115 
0.51 [0.12 - 0.90] 
N = 2,439 
1.29 [1.16 - 1.41] 
N = 51,286 
4.45 [4.07 - 4.83] 
N = 21,390 
1.59 [1.47 - 1.71] 
N = 51,591 
0.59 [0.51 - 0.66] 
N = 23,524 
Austria 
1.39 [1.09 - 1.69] 
N = 15,771 
0.00 [0.00 - 0.00] 
N = 252 
0.74 [0.57 - 0.91] 
N = 11,732 
3.19 [2.18 - 4.19] 
N = 3,787 
1.17 [0.88 - 1.46] 
N = 10,940 
0.22 [0.13 - 0.32] 
N = 4,831 
Belgium 
6.48 [5.76 - 7.19] 
N = 9,110 
1.23 [0.00 - 2.65] 
N = 340 
4.39 [3.63 - 5.15] 
N = 6,064 
12.24 [10.54 - 13.94] 
N = 2,706 
4.71 [4.15 - 5.28] 
N = 5,663 
1.76 [1.31 - 2.21] 
N = 3,447 
France 
2.44 [2.16 - 2.73] 
N = 15,481 
0.61 [0.00 - 1.36] 
N = 611 
1.40 [1.14 - 1.66] 
N = 10,061 
5.05 [4.30 - 5.80] 
N = 4,809 
2.07 [1.80 - 2.33] 
N = 11,005 
0.38 [0.27 - 0.49] 
N = 4,476 
Germany 
1.29 [1.11 - 1.47] 
N = 23,241 
0.40 [0.00 - 0.97] 
N = 772 
0.65 [0.51 - 0.80] 
N = 15,707 
2.86 [2.36 - 3.36] 
N = 6,762 
0.60 [0.48 - 0.72] 
N = 15,943 
0.69 [0.56 - 0.83] 
N = 7,298 
Luxembourg 
2.74 [2.20 - 3.28] 
N = 3,860 
2.59 [0.00 - 5.61] 
N = 115 
2.71 [2.09 - 3.33] 
N = 2,840 
2.85 [1.67 - 4.03] 
N = 905 
2.68 [2.14 - 3.21] 
N = 2,607 
0.06 [0.00 - 0.14] 
N = 1,253 
Netherlands 
3.15 [2.74 - 3.55] 
N = 7,652 
0.28 [0.00 - 0.82] 
N = 349 
2.23 [1.79 - 2.66] 
N = 4,882 
5.84 [4.85 - 6.84] 
N = 2,421 
2.82 [2.43 - 3.20] 
N = 5,433 
0.33 [0.19 - 0.47] 
N = 2,219 
 530 
 531 
Table 2. Crude prevalence (%) of self-reported vision problems provided by region and by country for three age groups and by sex. The 95% CI are given 532 
between brackets.  533 
An individual was considered to have vision problems if he declared having a lot of difficulty or no being able to see at all when answering to the item "difficulty 534 
in seeing, even when wearing glasses or contact lenses". An individual was considered to have no vision problem if he/she answered that they had no 535 
difficulty or some difficulty in seeing. 536 




Age Gender      N 
Prevalence (%) [95% 
CI] OR (95% CI) 
All M 142,662 1.70 [1.61 - 1.78] 
1.43 [1.34 - 1.54] 
 F 168,724 2.41 [2.31 - 2.51] 
50+ M 72,285 2.9 [2.74 - 3.05] 
1.52 [1.41 - 1.63] 
 
F 85,599 4.32 [4.13 - 4.51] 
60+ M 46,953 3.62 [3.40 - 3.84] 
1.60 [1.47 - 1.74] 
 
F  60,228 5.65 [5.38 - 5.92] 
70+ M 23,136 5.07 [4.70 - 5.45] 
1.67 [1.52 - 1.85] 
 
F 32,218 8.18 [7.74 - 8.62] 
85+ M 2,677 11.85 [10.25 - 13.45] 
1.55 [1.28 - 1.87] 
 
F 4,967 17.22 [15.68 - 18.76] 
 540 
 541 
Table 3. Age-adjusted prevalence of self-reported vision problems by sex for older individuals.542 
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 544 EHIS 2 (N = 302,093) 
  OR [95% CI] % Missing 
values among 
respondents Missing countries 
Physical health   
 
 Self-rated health (poor vs good) 4.48 [4.11 - 4.89] 3.00 - 
Limiting long-standing illness (yes vs no) 5.23 [4.82 - 5.67] 1.64 - 
Chronic illness (yes vs no) 2.53 [2.34 - 2.73] 1.39 - 
Functional limitations (yes vs no; age 65+) 6.04 [5.31 - 6.87] 3.62 NL, BE 
Mental health   
  
Depression (yes vs no) 4.55 [4.20 - 4.93] 13.90 BE, ES, NL 
Lifestyle   
 
 Daily smoking (yes vs no) 1.35 [1.23 - 1.48] 1.53 
 Physical activity (no vs yes) 2.26 [2.09 - 2.44] 9.26 BE, NL 
Near-daily alcohol consumption (yes vs no) 0.81 [0.71 - 0.93] 18.50 FR, IT, NL 
Economics   
 
 Wealth (higher versus low) 0.60 [0.55 - 0.65] 6.47 - 
Education (high vs intermediate) 0.77 [0.68 - 0.87] 0.69 - 
Education (low vs intermediate) 1.74 [1.61 - 1.89] 0.69 - 
Social life   
  
Social isolation (yes vs no) 2.79 [2.43 - 3.21] 11.72 BE, FR 
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Table 4. Univariate regression analysis between self-reported vision problems and health, socio-economic and life style related variables in Europe in the 546 




EHIS 2 (N = 302,093) 
  OR [95% CI] 
Physical health 
  
Self-rated health (poor vs good) 1.87 [1.69 - 2.07] 
Limiting long-standing illness (yes vs no) 2.66 [2.42 - 2.92] 
Chronic illness (yes vs no) 1.46 [1.35 - 1.57] 
Mental health 
  
Depression (yes vs no) 2.16 [2.01 - 2.32] 
Lifestyle 
  
Daily smoking (yes vs no) 1.11 [1.01 - 1.23] 
Physical activity (no vs yes) 1.31 [1.21 - 1.42] 
Near-daily alcohol consumption (yes vs no) 0.93 [0.80 - 1.08] 
Economics 
  
Wealth (higher versus low) 0.80 [0.73 - 0.86] 
Education (high vs intermediate) 0.95 [0.84 - 1.08] 
Education (low vs intermediate) 1.29 [1.19 - 1.40] 
Social life 
  
Social isolation (yes vs no) 1.45 [1.26 - 1.67] 
 550 
Table 5. Multivariate regression analysis between self-reported vision problems and health, socio-economic and life style related variables in Europe in the 551 
adult population. 552 
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Supporting Information 553 
Table S1. Detailed definition of the variables tested for association with visual problems. 554 
Table S2. Univariate regression analysis between vision problems and health, socio-economic and life 555 
style related variables, by region and by country, in the adult population.   556 
* Dashes are displayed where the ORs could not be computed because no survey for Portugal and 557 
Malta specified a high education level. 558 
Table S3. Prevalence of self-reported vision problems in different population-based studies from 559 
developed countries. 560 
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